Characterization of premature liver polyploidy in DNA repair (Ercc1)-deficient mice

Hepatology

Volumn 38, Issue 4, 2003, Pages 958-966

  Chipchase, Michael D ^b   O'Neill, Mary ^b   Melton, David W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; ENDONUCLEASE; ERCC1 XPF PROTEIN; MESSENGER RNA; PROTEIN P21; UNCLASSIFIED DRUG;

AGING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DNA CROSS LINKING; DNA DAMAGE; DNA REPAIR; EXCISION REPAIR; GENE ERCC1; GENE OVEREXPRESSION; GENETIC RECOMBINATION; KNOCKOUT GENE; LIVER CELL; LIVER INJURY; LIVER POLYPLOIDY; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PHENOTYPE; POLYPLOIDY; PRIORITY JOURNAL; TRANSGENE;

EID: 0141866925     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50421     Document Type: Article

References (29)

1. Friedberg EC, Walker GC, Siede W. DNA repair and mutagenesis. Washington DC: ASM Press, 1995.
2. Paques F, Haber JE. Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 1999;63:349-404.
3. Li L, Peterson CA, Lu X, Wei P, Legerski RJ. Interstrand cross-links induce DNA synthesis in damaged and undamaged plasmids in mammalian cell extracts. Mol Cell Biol 1999;19:5619-5630.
4. Kuraoka I, Kobertz WR, Ariza RR, Biggerstaff M, Essigmann JM, Wood RD. Repair of an interstrand DNA cross-link initiated by ERCC1-XPF repair/recombination nuclease. J Biol Chem 2000;275:26632-26636.
5. McWhir J, Selfridge J, Harrison DJ, Squires S, Melton DW. Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning. Nat Genet 1993;5:217-224.
6. 2 arrest in hepatocytes and a reduction in liver binucleation: the role of p53 and p21. FASEB J 2000;14:1073-1082.
7. Epstein CJ, Gatens EA. Nuclear ploidy in mammalian parenchymal liver cells. Nature 1967;214:1050-1051.
8. Bohm N, Noltemeyer N. Development of binuclearity and DNA-polyploidization in the growing mouse liver. Histochemistry 1981;72:55-61.
9. Selfridge J, Hsia K.-T, Redhead NJ, Melton DW. Correction of liver dysfunction in DNA repair-deficient mice with an ERCC1 transgene. Nucl Acids Res 2001;29:4541-4550.
10. de Vries A, van Oostrom CT, Hofhuis FM, Dortant PM, Berg RJ, de Gruijl FR, Wester PW, et al. Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA. Nature 1995;377:169-173.
11. Sands AT, Abuin A, Sanchez A, Conti CJ, Bradley A. High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature 1995;377:162-165.
12. Fisher PB. p21 in differentiation. DNA-repair, tumor progression, and senescence. Mol Cell Differ 1996;4:U7.
13. Wu H, Wade M, Krall L, Grisham J, Xiong Y, Van Dyke T. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration. Genes Dev 1996;10:245-260.
14. Biesterfeld S, Gerres K, Fischer-Wein G, Bocking A. Polyploidy in non-neoplastic tissues. J Clin Pathol 1994;47:38-42.
15. Medvedev ZA. Age-related polyploidization of hepatocytes: the cause and possible role. A mini-review. Exp Gerontol 1986;21:277-282.
16. Bellamy CO, Clarke AR, Wyllie AH, Harrison DJ. p53 deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage. FASEB J 1997;11:591-599.
17. Gorla GR, Malhi H, Gupta S. Polyploidy associated with oxidative injury attenuates proliferative potential of cells. J Cell Sci 2001;114:2943-2951.
18. Sorenson CM, Barry MA, Eastman A. Analysis of events associated with cell cycle arrest at G2 phase and cell death introduced by cisplatin. J Natl Cancer Inst 1990;82:749-755.
19. Grossman KF, Brown JC, Moses RE. DNA cross-links do not inhibit S-phase and cause only a G2/M arrest in Saccharomyces cerevisiae. Mut Res 1999;434:29-39.
20. Elbendary A, Berchuck A, Davis P, Havrilesky L, Bast RCJ, Iglehart JD, Marks JR. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ 1994;5:1301-1307.
21. Jiang H, Lin J, Su ZZ, Collart FR, Huberman E, Fisher PB. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 1994;9:3397-3406.
22. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, et al. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 1995;267:1024-1027.
23. Albrecht JH, Meyer AH, Hu MY. Regulation of cyclin-dependent kinase inhibitor p21 (WAF1/Cip1/Sdi1) gene expression in hepatic regeneration. HEPATOLOGY 1997;25:557-563.
24. Bates S, Ryan KM, Phillips AC, Vousden KH. Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression. Oncogene 1998;17:1691-1703.
25. Niculescu AB, Chen X, Smeets M, Hengst L, Prives C, Reed SI. Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol 1998;18:629-643.
26. Waldman T, Lengauer C, Kinzler KW, Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 1996;381:713-716.
27. Sigal SH, Rajvanshi P, Gorla GR, Sokhi RP, Saxena R, Gebhard DRJ, Reid LM, et al. Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell ageing events. Am J Physiol 1999;276: G1260-G1272.
28. Zhang H, Hannon GJ, Casso D, Beach D. p21 is a component of active cell cycle kinases. Cold Spring Harb Symp Quant Biol 1994;59:21-29.
29. Melton DW, Ketchen A-M, Nuñez F, Bonatti-Abbondandolo S, Abbondanolo A, Squires S, Johnson RT. Cells from ERCC1-deficient mice show increased genome instability and a reduced frequency of S-phase-dependent illegitimate chromosome exchange, but a normal frequency of homologous recombination. J Cell Sci 1998;111:395-404.